U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
DINUTUXIMAB BETA
INN   WHO-DD  
INN  
Official Name English
dinutuximab beta [INN]
Common Name English
QARZIBA
Brand Name English
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO LIGHT CHAIN, DIMER
Common Name English
Dinutuximab beta [WHO-DD]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/12/1062
Created by admin on Sat Dec 16 09:31:28 GMT 2023 , Edited by admin on Sat Dec 16 09:31:28 GMT 2023
Code System Code Type Description
INCB IDS CODE
10137
Created by admin on Sat Dec 16 09:31:28 GMT 2023 , Edited by admin on Sat Dec 16 09:31:28 GMT 2023
PRIMARY
INN
10137
Created by admin on Sat Dec 16 09:31:28 GMT 2023 , Edited by admin on Sat Dec 16 09:31:28 GMT 2023
PRIMARY
EVMPD
SUB174757
Created by admin on Sat Dec 16 09:31:28 GMT 2023 , Edited by admin on Sat Dec 16 09:31:28 GMT 2023
PRIMARY
SUBSTANCE RECORD
DINUTUXIMAB BETA
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966